In vitro effect of ۱-methyltryptophan isomers on epithelial-mesenchymal transition transcription factors in tubular epithelial cells after ischemia-reperfusion injury
محل انتشار: مجله آرشیو رازی، دوره: 79، شماره: 2
سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 19
فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_ARCHRAZI-79-2_008
تاریخ نمایه سازی: 18 اردیبهشت 1403
چکیده مقاله:
The compound ۱-methyltryptophan (۱-MT) has been shown to act protectively in renal ischemia-reperfusion injury. Toll-like receptor ۴ (TLR-۴) signaling is also a regular process of epithelial to mesenchymal transition (EMT) that can after Ischemia-reperfusion injury (IRI) result in as an increase of renal fibrosis. EMT is associated with specific transcription factors – Snai۱, Snai۲, Zeb۱ and Twist. ۱-MT could regulate EMT and act as antifibrotic agent. This study aimed to investigate the effect of ۱-MT on EMT transcription factors in tubular epithelial cells that underwent ۳۰ min. Renal tubular epithelial cells (TECs) were isolated from Lewis rats using a standard protocol with Fe۲O۳ magnetic separation and selective media as previously mentioned. ischemia and ۴۸ hours of reperfusion. Cells were cultivated and divided into ۴ groups: C-TECs– control cells, IRI-TECs – IRI-induced TECs, D-IRI-TECs – IRI-induced TECs treated with ۱-methyl-D-tryptophan, L-IRI-TECs – IRI-induced TECs treated with ۱-methyl-L-tryptophan. IRI was induced in all groups for ۳۰ min by mineral oil (except for C-TECs) followed by ۴۸ hours of reperfusion. RNA and proteins were isolated from harvested cells. Using semi-quantitative PCR (RT-sqPCR) we assessed the relative mRNA expression of EMT transcription factors Snai۱, Snai۲, Zeb۱, and Twist. Hereby we have shown, that the treatment of ischemia-induced TECs with both ۱-MT isomers lowers the expression of EMT transcription factors Snai۱ and Zeb۱ that were increased by ischemia and reperfusion of TECs. This could act favorably in renal IRI decreasing EMT and renal fibrosis, therefore showing the potential of ۱-MT as a part of therapy in renal transplantation aimed at renal ischemia-reperfusion injury.
کلیدواژه ها:
نویسندگان
Noura AliNejad Kasbakhi
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovak Republic
Diana Vavrincová
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovak Republic
Diana Cepcova
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovak Republic